In this invention a new compound, a ligand to the peripheral-type benzodiazepine receptor (PBR), is introduced. The PBR-ligand attachment induces anti-apoptotic activity, which is of extreme value in neurodegenerative diseases and traumatic brain damage. Traumatic brain injury is the leading cause of disability in individuals below the age of 40.

1586128594.png)